Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEGA trial: Aspirin for prevention of metachronous gastric cancer after ESD
jRCTs031180437Completed
- Sponsor
- Japan Strategic Medical Administration Research Center
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Randomised trial of aspirin in gastric cancer (GC) and gastric adenocarcinoma (2 arms), sponsored by Japan Strategic Medical Administration Research Center. Primary endpoint: Cumulative incidence of metachronous gastric carcinoma at 5 years. Started Jul 2019; status: completed.
02
Drugs
aspirin
03
Conditions
gastric cancer (GC)gastric adenocarcinoma
Beyond the preview
Go deeper on jRCTs031180437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180437.